Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cloning and stem cells].

Ximo Soriano Felipe1, Antonio Guerrero Espejo, Santiago Bonanad Boix

  • 1Area de Diagnóstico Biológico. Hospital de La Ribera. Alzira. Valencia. España.

Medicina Clinica
|February 18, 2004
PubMed
Summary

Cloning technologies advance regenerative medicine, enabling in vitro stem cell differentiation for cellular and tissue therapies. While reproductive cloning faces debate, therapeutic cloning shows significant medical promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvements in pharmacokinetics, bleeding control, and cost analysis after PK-guided transition to extended-half-life factor IX in hemophilia B: A multicentric study.

Thrombosis research·2026
Same author

[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2025
Same author

Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in the therapy of hemophilia A in clinical practice.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2024
Same author

Suitability and readiness assessment of organizational resources for the implementation of gene therapy in hemophilia in Spain and Portugal: A survey-based study.

Thrombosis research·2024
Same author

Síndrome de Wiskott-Aldrich en España: incidencia, mortalidad y sesgo de género durante 21 años.

Revista clinica espanola·2023
Same author

Osteoarticular tuberculosis mortality in Spain between 1997 and 2018.

Reumatologia clinica·2023

Area of Science:

  • Biotechnology and Regenerative Medicine
  • Cellular and Molecular Biology

Context:

  • Advancements in cloning technologies offer novel therapeutic strategies.
  • Stem cell differentiation in vitro is a key application.
  • Significant progress in tissue engineering and transplantation.

Purpose:

  • To summarize key applications of cloning and stem cell technologies.
  • To discuss associated technical challenges and ethical considerations.
  • To present an academic and professional perspective on cloning's medical uses.

Summary:

  • Cloning technologies facilitate the production of cellular and tissue replacements through in vitro stem cell differentiation.
  • The scientific community largely supports therapeutic cloning while opposing reproductive cloning.
  • Current research focuses on the practical applications and inherent challenges of these technologies.

Impact:

  • Potential to revolutionize medical treatments through regenerative therapies.
  • Improves prospects for tissue repair and organ transplantation.
  • Drives innovation in biotechnology and personalized medicine.

Related Experiment Videos